Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

PURPOSE: Most colon cancers show low sensitivity to treatment with oxaliplatin and a specific strategy is needed to overcome this problem. Our approach uses RNA interference to silence the expression of target genes responsible for the development of oxaliplatin resistance. Profile analysis of genes...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bavykin, Andrey S, Korotaeva, Alexandra A, Poyarkov, Stanislav V, Syrtsev, Alexandr V, Tjulandin, Sergei A, Karpukhin, Alexandr V
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2013
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789649/
https://ncbi.nlm.nih.gov/pubmed/24098083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S44893
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items